Datakosa Limited Secures BSE Approval for Rs 4 Crore Fundraise

Total Capital to be Raised: Rs 3.99 Crore | Shares to be Issued: 23,52,940 Equity Shares

Reader Takeaway: Regulatory clearance marks a critical step for capital infusion; monitor post-allotment listing filings for final execution.

What just happened

Datakosa Limited has officially received in-principle approval from the BSE for a preferential allotment of equity shares. The company plans to issue 23,52,940 fully paid-up shares to non-promoter entities. The issue price is set at Rs 17 per share, which comprises a face value of Rs 10 and a premium of Rs 7. This transaction will result in an aggregate fund infusion of approximately Rs 399.99 lakh.

Why this matters

This regulatory green light represents a vital milestone in the company's capital raising strategy. By securing this approval, Datakosa has met a core prerequisite set by the exchange following board approval on August 11, 2026, and subsequent shareholder approval obtained on September 09, 2026. Successful completion of this issue will strengthen the company's equity base.

Regulatory Compliance and Conditions

In its letter dated October 07, 2026, the BSE highlighted several mandatory compliance requirements. The company is now tasked with:

• Implementing robust internal controls to monitor trading activities of the proposed allottees.
• Ensuring strict adherence to SEBI (ICDR) Regulations, specifically prohibiting intra-day trading by the allottees.
• Submitting a formal listing application to the exchange within 20 days of the actual allotment.

What to track next

Investors should watch for the company's subsequent filings regarding the actual allotment of the shares. Once the funds are received and shares are issued, the company must fulfill post-issue formalities to finalize the listing. The speed and transparency of these filings will be key indicators of the issue's successful execution.